HomeNMLSF • OTCMKTS
add
Restart Life Sciences Corp
Previous close
$0.081
Year range
$0.030 - $0.10
Market cap
3.80M CAD
Avg Volume
799.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 167.84K | 40.39% |
Net income | -210.98K | -145.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -167.38K | -40.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 138.76K | -44.63% |
Total assets | 153.31K | -42.33% |
Total liabilities | 301.63K | -64.59% |
Total equity | -148.32K | — |
Shares outstanding | 36.05M | — |
Price to book | ∞ | — |
Return on assets | -194.76% | — |
Return on capital | 979.82% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -210.98K | -145.91% |
Cash from operations | -78.87K | -1,672.67% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -78.87K | -1,672.67% |
Free cash flow | -17.54K | 94.07% |
About
Founded
2004
Headquarters
Website
